Skip to main content
Equibles

MetLife Investment Management, LLC

Position in REPL — Replimune Group, Inc.

CIK 1529735 Whippany, NJ
Back to REPL Full portfolio

Position in REPL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$513,360
+$219,945 QoQ
Shares Held
46,374
+20.9% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 199 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REPL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $433,929,439 across 249 Biotechnology names. REPL ranks #122 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HALO
Halozyme Therapeutics, Inc.
 402,605 $31,511,893
2 PRAX
Praxis Precision Medicines, Inc.
 90,543 $30,312,890
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 58,072 $28,846,104
4 FTRE
Fortrea Holdings Inc.
 1,362,169 $23,701,740
5 AXSM
Axsome Therapeutics, Inc.
 89,662 $21,946,567
6 IMNM
Immunome Inc.
 859,076 $18,203,820
7 REGN
Regeneron Pharmaceuticals, Inc.
 22,880 $14,266,595
8 CYTK
Cytokinetics Inc
 140,046 $11,930,518

All Filings in REPL

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $513,360 46,374
2026-03-31 $293,415 38,355
2025-12-31 $333,668 34,328
2025-09-30 $169,854 40,538
2025-06-30 $377,155 40,598
2025-03-31 $395,830 40,598
2024-12-31 $456,050 37,659
2024-09-30 $385,068 35,134
2024-06-30 $260,262 28,918
2024-03-31 $217,689 26,645
2023-12-31 $224,617 26,645
2023-09-30 $367,950 21,505
2023-06-30 $499,346 21,505
2023-03-31 $433,976 24,574
2022-12-31 $588,227 21,626
2022-09-30 $373,481 21,626
2022-06-30 $265,853 15,209
2022-03-31 $258,248 15,209
2021-12-31 $267,341 9,865
2021-09-30 $292,398 9,865
2021-06-30 $379,013 9,865
2021-03-31 $300,981 9,865
2020-12-31 $376,349 9,865
2020-09-30 $227,092 9,865
2020-06-30 $245,145 9,865